DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka

Country: 🇱🇰Sri Lanka

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Atorvastatin Calcium Tablets, 80 mg

First Posted Date: 2012-07-20

Last Posted Date: 2012-07-20

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 77

Registration Number: NCT01645449

Locations: 🇩🇪
Nuvisan Pharma Services GmbH & Co. KG, Neu-Ulm, Germany

Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ibandronate sodium

First Posted Date: 2012-06-26

Last Posted Date: 2012-06-28

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 100

Registration Number: NCT01627886

Locations: 🇮🇳
BA Research India Ltd, Ahmedabad, Gujarat, India

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ropinirole

First Posted Date: 2012-06-26

Last Posted Date: 2012-09-28

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 48

Registration Number: NCT01627834

Locations: 🇮🇳
GVK Biosciences Pvt. Ltd, Ameerpet, Hyderabad, India

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ropinirole

First Posted Date: 2012-06-26

Last Posted Date: 2012-09-28

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 48

Registration Number: NCT01627847

Locations: 🇮🇳
GVK Biosciences Pvt. Ltd, Ameerpet, Hyderabad, Andhra Pradesh, India

Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Clopidogrel

First Posted Date: 2012-06-18

Last Posted Date: 2012-06-25

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 68

Registration Number: NCT01621763

Locations: 🇮🇳
Lambda Therapeutic Research Ltd, Ahmedabad, Gujrat, India

Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions

Phase 1

Completed

Conditions: Fasting

Interventions: Drug: Clopidogrel

First Posted Date: 2012-06-18

Last Posted Date: 2012-06-18

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 68

Registration Number: NCT01621750

Locations: 🇮🇳
Lambda Therapeutic Research Ltd, Ahmedabad, Gujrat, India

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ziprasidone Hydrochloride

First Posted Date: 2012-04-20

Last Posted Date: 2012-04-20

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 56

Registration Number: NCT01581866

Locations: 🇺🇸
SFBC Ft. Myers, Inc., Fort Myers, Florida, United States

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ziprasidone Hydrochloride

First Posted Date: 2012-04-20

Last Posted Date: 2012-04-20

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 38

Registration Number: NCT01581879

Locations: 🇺🇸
SFBC Ft. Myers, Inc., Fort Myers, Florida, United States

Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Divalproex Sodium

First Posted Date: 2012-04-20

Last Posted Date: 2012-04-20

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 54

Registration Number: NCT01581775

Locations: 🇮🇳
Veeda Clinical Research, India, Ahmedabad, Gujrat, India

Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Divalproex Sodium

First Posted Date: 2012-04-20

Last Posted Date: 2012-04-20

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 54

Registration Number: NCT01581788

Locations: 🇮🇳
Veeda Clinical Research, India, Ahmedabad, Gujrat, India

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy